Inger Anne Næss

2.4k citations

26 papers · 1.7k indexed · 1 hit paper · h-index 15

Internal Medicine top 0.2%
Hematology top 1%
Cardiology and Cardiovascular Medicine top 5%
Surgery top 10%
Emergency Medical Services top 2%

Co-authors: Suzanne C. Cannegieter Jens Hammerstrøm Sverre Christian Christiansen Frits R. Rosendaal Pål Romundstad Sigrid K. Brækkan John‐Bjarne Hansen P. R. Romundstad
Topics: Venous Thromboembolism Diagnosis and Management (16 papers)Blood Coagulation and Thrombosis Mechanisms (11 papers)Acute Myocardial Infarction Research (4 papers)
Cited by: Internal Medicine Hematology Cardiology and Cardiovascular Medicine
Journals: CirculationSHILAP Revista de lepidopterologíaBlood
Partner nations: Norway Netherlands Denmark

In The Last Decade

Inger Anne Næss

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and mortality of venous thrombosis: a population‐based study

2007 1.0k citations Inger Anne Næss, Sverre Christian Christiansen et al. Journal of Thrombosis and Haemostasis profile →

Peers

Countries citing papers authored by Inger Anne Næss

Since Specialization

Citations

This map shows the geographic impact of Inger Anne Næss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Anne Næss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Anne Næss more than expected).

Fields of papers citing papers by Inger Anne Næss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Anne Næss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Anne Næss. The network helps show where Inger Anne Næss may publish in the future.

Co-authorship network of co-authors of Inger Anne Næss

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Anne Næss. A scholar is included among the top collaborators of Inger Anne Næss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Anne Næss. Inger Anne Næss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study 2023 ·Blood Advances ·Monique J. T. Crobach,(unknown),Sigrid K. Brækkan,Marianne Tang Severinsen,Jens Hammerstrøm,(unknown),Søren Risom Kristensen,(unknown),Anne Tjønneland,Henri H. Versteeg,Kim Overvad,John‐Bjarne Hansen,Inger Anne Næss,Suzanne C. Cannegieter	20
2	Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort 2021 ·Scientific Reports ·(unknown),(unknown),Marianne Tang Severinsen,Jens Hammerstrøm,Søren Risom Kristensen,Suzanne C. Cannegieter,(unknown),Anne Tjønneland,F.R. Rosendaal,Kim Overvad,Inger Anne Næss,John‐Bjarne Hansen,Sigrid K. Brækkan	5
3	Prothrombotic genotypes and risk of venous thromboembolism in occult cancer 2021 ·Thrombosis Research ·(unknown),(unknown),Kristian Hveem,Marianne Tang Severinsen,Maiken E. Gabrielsen,Søren Risom Kristensen,Inger Anne Næss,Kristian Hindberg,Anne Tjønneland,Sigrid K. Brækkan,John‐Bjarne Hansen	5
4	Syfilis med synstap 2021 ·Tidsskrift for Den norske legeforening ·(unknown),(unknown),Inger Anne Næss,David Stevens	2
5	Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort 2018 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),Marianne Tang Severinsen,Suzanne C. Cannegieter,(unknown),Kim Overvad,Jens Hammerstrøm,Anne Tjønneland,Inger Anne Næss,Sigrid K. Brækkan,F.R. Rosendaal,Søren Risom Kristensen,John‐Bjarne Hansen	17
6	Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort 2018 ·SHILAP Revista de lepidopterología ·Inger Lise Gade,Sigrid K. Brækkan,Inger Anne Næss,John‐Bjarne Hansen,Suzanne C. Cannegieter,Frits R. Rosendaal,Kim Overvad,Kristian Hindberg,Jens Hammerstrøm,(unknown),Anne Tjønneland,Marianne Tang Severinsen,Søren Risom Kristensen	4
7	Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort 2017 ·Thrombosis Research ·Inger Lise Gade,Sigrid K. Brækkan,Inger Anne Næss,J.-B. Hansen,Frits R. Rosendaal,Suzanne C. Cannegieter,Kim Overvad,(unknown),Jens Hammerstrøm,(unknown),Anne Tjønneland,Søren Risom Kristensen,Marianne Tang Severinsen	20
8	The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort 2017 ·Journal of Thrombosis and Haemostasis ·Inger Lise Gade,Sigrid K. Brækkan,Inger Anne Næss,John‐Bjarne Hansen,Suzanne C. Cannegieter,Kim Overvad,(unknown),Jens Hammerstrøm,(unknown),Anne Tjønneland,Søren Risom Kristensen,Marianne Tang Severinsen	33
9	Venous thromboembolism and subsequent permanent work‐related disability 2016 ·Journal of Thrombosis and Haemostasis ·Sigrid K. Brækkan,Scott D. Grosse,Ekwutosi M. Okoroh,James H. Tsai,Suzanne C. Cannegieter,Inger Anne Næss,Steinar Krokstad,John‐Bjarne Hansen,Finn Egil Skjeldestad	35
10	Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort 2015 ·Clinical Epidemiology ·(unknown),Marianne Tang Severinsen,Jens Hammerstrøm,Sigrid K. Brækkan,Søren Risom Kristensen,Suzanne C. Cannegieter,(unknown),Anne Tjønneland,Frits R. Rosendaal,(unknown),Kim Overvad,Inger Anne Næss,John‐Bjarne Hansen	22
11	Venous thromboembolism and subsequent receipt of disability pension - a population-based prospective cohort study 2013 ·Journal of Thrombosis and Haemostasis ·(unknown),Scott D. Grosse,Ekwutosi M. Okoroh,Sigrid K. Brækkan,Suzanne C. Cannegieter,Inger Anne Næss,Steinar Krokstad,J.-B. Hansen	2
12	Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism Pooled Analysis of Five Prospective General Population Cohorts 2013 ·Journal of Vascular Surgery ·Bakhtawar K. Mahmoodi,(unknown),Inger Anne Næss	6
13	The relationship between body mass index, activated protein C resistance and risk of venous thrombosis 2012 ·Journal of Thrombosis and Haemostasis ·Sverre Christian Christiansen,Willem M. Lijfering,Inger Anne Næss,Jens Hammerstrøm,Astrid van Hylckama Vlieg,Frits R. Rosendaal,Suzanne C. Cannegieter	27
14	Increased levels of free thyroxine and risk of venous thrombosis in a large population‐based prospective study 2012 ·Journal of Thrombosis and Haemostasis ·J. Debeij,Olaf M. Dekkers,Bjørn Olav Åsvold,Sverre Christian Christiansen,Inger Anne Næss,Jens Hammerstrøm,Frits R. Rosendaal,Suzanne C. Cannegieter	25
15	Overlevelse hos voksne med akutt lymfoblastisk leukemi 2010 ·Tidsskrift for Den norske legeforening ·Jon‐Magnus Tangen,Yngvar Fløisand,Einar Haukås,Inger Anne Næss,Tove Skjelbakken,Camilla Stapnes,Geir E. Tjønnfjord	2
16	Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2) 2009 ·Haematologica ·Petter Quist‐Paulsen,Inger Anne Næss,Suzanne C. Cannegieter,P. R. Romundstad,Sverre Christian Christiansen,F. R. Rosendaal,Jens Hammerstrøm	81
17	Overlevelse hos voksne med akutt myelogen leukemi 2008 ·Tidsskrift for Den Norske Laegeforening ·Jon‐Magnus Tangen,Yngvar Fløisand,(unknown),Einar Haukås,Inger Anne Næss,Tove Skjelbakken	1
18	Inflammatory Cytokines as Risk Factors for a First Venous Thrombosis: A Prospective Population-Based Study 2006 ·PLoS Medicine ·Sverre Christian Christiansen,Inger Anne Næss,Suzanne C. Cannegieter,Jens Hammerstrøm,Frits R. Rosendaal,Pieter H. Reitsma	71
19	A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study) 2005 ·Journal of Thrombosis and Haemostasis ·Inger Anne Næss,Sverre Christian Christiansen,Suzanne C. Cannegieter,Frits R. Rosendaal,(unknown)	50
20	[Lead poisoning--a case report]. 2002 ·PubMed ·Tore Amundsen,Inger Anne Næss,Jens Hammerstrøm,Robert Brudevold,Kristian S. Bjerve	2

About Inger Anne Næss

Inger Anne Næss is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (16 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Acute Myocardial Infarction Research (4 papers). The work is most often cited by research in Internal Medicine (1.2k citations), Hematology (667 citations) and Cardiology and Cardiovascular Medicine (622 citations). Inger Anne Næss has collaborated with scholars based in Norway, Netherlands and Denmark. Frequent co-authors include Suzanne C. Cannegieter, Jens Hammerstrøm, Sverre Christian Christiansen, Frits R. Rosendaal, Pål Romundstad, Sigrid K. Brækkan, John‐Bjarne Hansen, P. R. Romundstad, F. R. Rosendaal and Pieter H. Reitsma. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact